NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 341 filers reported holding NEKTAR THERAPEUTICS in Q2 2019. The put-call ratio across all filers is 2.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $357,000 | -59.4% | 66,185 | +1.6% | 0.00% | -60.0% |
| Q4 2021 | $880,000 | -23.3% | 65,132 | +1.9% | 0.01% | -28.6% |
| Q3 2021 | $1,148,000 | +8.3% | 63,912 | +3.5% | 0.01% | +16.7% |
| Q2 2021 | $1,060,000 | -16.6% | 61,753 | -2.8% | 0.01% | -25.0% |
| Q1 2021 | $1,271,000 | +17.4% | 63,553 | -0.3% | 0.01% | +14.3% |
| Q4 2020 | $1,083,000 | +2.8% | 63,713 | +0.3% | 0.01% | -12.5% |
| Q3 2020 | $1,054,000 | -28.4% | 63,553 | -0.1% | 0.01% | -33.3% |
| Q2 2020 | $1,473,000 | +19.1% | 63,613 | -8.2% | 0.01% | +9.1% |
| Q1 2020 | $1,237,000 | +41.5% | 69,293 | +71.1% | 0.01% | +57.1% |
| Q4 2019 | $874,000 | +19.6% | 40,503 | +0.9% | 0.01% | 0.0% |
| Q3 2019 | $731,000 | -84.6% | 40,153 | -70.0% | 0.01% | -75.9% |
| Q2 2019 | $4,760,000 | +23.5% | 133,794 | +16.6% | 0.03% | +16.0% |
| Q1 2019 | $3,854,000 | +2.0% | 114,704 | -0.3% | 0.02% | -10.7% |
| Q4 2018 | $3,780,000 | -45.4% | 115,005 | +1.2% | 0.03% | -36.4% |
| Q3 2018 | $6,925,000 | +303.1% | 113,603 | +223.0% | 0.04% | +144.4% |
| Q2 2018 | $1,718,000 | – | 35,176 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |